Rep. Barton questions FDA's use of "social policy" in home-use diagnostics review.
This article was originally published in The Tan Sheet
Executive Summary
REP. BARTON QUESTIONS FDA HOME-USE DIAGNOSTIC TEST REVIEW in a May 8 letter to FDA Commissioner David Kessler, MD. House Com-merce/Over-sight Subcommittee Chairman Joe Barton (R-Tex.) asked Kessler, "What is FDA's social policy position (as opposed to safety and efficacy) on home drug testing?" Barton requested that the agency respond to the letter by May 22.